Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: A phase III, randomized, multicentre, lot-to-lot consistency study
Kirsten P Perrett, Jodie McVernon, Peter C Richmond, Helen Marshall, Michael Nissen, Allison August, Sandra Percell, Daniela Toneatto, Terry Nolan
VACCINE | ELSEVIER SCI LTD | Published : 2015
Awarded by Australian National Health and Medical Research Council
This study was funded by Novartis Vaccines. Dr. Perrett, and A/Professors McVernon and Marshall (1016272) are recipients of Research Fellowships from the Australian National Health and Medical Research Council.